offered large sums of money to lure the Germany-based company CureVac to
the United States and to secure exclusive rights to a vaccine."
"The American regime has committed an extremely unfriendly act,” said
Social Democrat MP Karl Lauterbach, who said that German health workers
on the front lines — as well as people around the world — needed to have
access to something developed in Germany, and that no country should be
able to purchase exclusive access to the vaccine.